UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	September 16, 2025

Accession Number:	0001104659-25-090236
Submission Type:	POS AM
CIK: 0001722964 Company Name: Y-mAbs Therapeutics, Inc. File Number: 333-271006